ATA14642003A - Impfstoff für die alzheimer-krankheit - Google Patents
Impfstoff für die alzheimer-krankheitInfo
- Publication number
- ATA14642003A ATA14642003A AT0146403A AT14642003A ATA14642003A AT A14642003 A ATA14642003 A AT A14642003A AT 0146403 A AT0146403 A AT 0146403A AT 14642003 A AT14642003 A AT 14642003A AT A14642003 A ATA14642003 A AT A14642003A
- Authority
- AT
- Austria
- Prior art keywords
- arg
- glu
- asp
- tyr
- phe
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (28)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0146403A AT413945B (de) | 2003-01-14 | 2003-09-17 | Impfstoff für die alzheimer-krankheit |
PT04701585T PT1583774E (pt) | 2003-01-14 | 2004-01-13 | Métodos para prevenção e tratamento de doença de alzheimer (da) |
CA2513218A CA2513218C (en) | 2003-01-14 | 2004-01-13 | Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |
PT05107898T PT1679319E (pt) | 2003-01-14 | 2004-01-13 | Métodos para a prevenção e o tratamento da doença de alzheimer (ad) |
DK05107898T DK1679319T3 (da) | 2003-01-14 | 2004-01-13 | Fremgangsmåde til forebyggelse og behandling af Alzheimers sygdom (AD) |
AU2004204349A AU2004204349B2 (en) | 2003-01-14 | 2004-01-13 | Methods for preventing and treating Alzheimer's disease (AD) |
ES04701585T ES2339447T3 (es) | 2003-01-14 | 2004-01-13 | Procedimiento para prevenir y tratar la enfermedad de alzehimer (ad). |
PL378333A PL209989B1 (pl) | 2003-01-14 | 2004-01-13 | Zastosowanie związku peptydowego oraz szczepionka przeciwko chorobie Alzheimera |
AT04701585T ATE458753T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
SI200431399T SI1583774T1 (sl) | 2003-01-14 | 2004-01-13 | Postopki za preprečevanje in zdravljenje Alzheimerjeve bolezni AD |
DE602004025668T DE602004025668D1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
SI200430549T SI1679319T1 (sl) | 2003-01-14 | 2004-01-13 | Postopki za preprecevanje in zdravljenje Alzheimerjeve bolezni |
AT05107898T ATE376559T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
ES05107898T ES2296084T3 (es) | 2003-01-14 | 2004-01-13 | Procedimientos para la prevencion y el tratamiento de la enfermedad de alzheimer (ea). |
DE602004009705T DE602004009705T2 (de) | 2003-01-14 | 2004-01-13 | Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit |
US10/540,551 US7732568B2 (en) | 2003-01-14 | 2004-01-13 | Methods for preventing and treating Alzheimer's disease |
JP2006500553A JP4547373B2 (ja) | 2003-01-14 | 2004-01-13 | アルツハイマー病の予防および治療方法 |
DK04701585.4T DK1583774T3 (da) | 2003-01-14 | 2004-01-13 | Fremgangsmåder til forebyggelse og behandling af alzheimers sygdom |
CN2011103110387A CN102526699A (zh) | 2003-01-14 | 2004-01-13 | 预防和治疗阿尔茨海默病(ad)的方法 |
CN200480002213.2A CN1826354B (zh) | 2003-01-14 | 2004-01-13 | 预防和治疗阿尔茨海默病(ad)的方法 |
EP04701585A EP1583774B1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
EP05107898A EP1679319B1 (de) | 2003-01-14 | 2004-01-13 | Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit |
PCT/EP2004/000162 WO2004062556A2 (en) | 2003-01-14 | 2004-01-13 | Methods for preventing and treating alzheimer’s disease (ad) |
HK06111905.5A HK1091499A1 (en) | 2003-01-14 | 2006-10-27 | Methods for preventing and treating alzheimers disease (ad) (ad) |
CY20081100069T CY1107146T1 (el) | 2003-01-14 | 2008-01-17 | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) |
JP2010051012A JP5282058B2 (ja) | 2003-01-14 | 2010-03-08 | アルツハイマー病の予防および治療方法 |
US12/752,451 US20110015131A1 (en) | 2003-01-14 | 2010-04-01 | Methods for preventing and treating alzheimer's disease (ad) |
CY20101100399T CY1110634T1 (el) | 2003-01-14 | 2010-05-07 | Μεθοδοι προληψης και θεραπειας της νοσου του αλτσχαϊμερ (ad) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT362003 | 2003-01-14 | ||
AT0146403A AT413945B (de) | 2003-01-14 | 2003-09-17 | Impfstoff für die alzheimer-krankheit |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA14642003A true ATA14642003A (de) | 2005-11-15 |
AT413945B AT413945B (de) | 2006-07-15 |
Family
ID=32714004
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0146403A AT413945B (de) | 2003-01-14 | 2003-09-17 | Impfstoff für die alzheimer-krankheit |
AT05107898T ATE376559T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
AT04701585T ATE458753T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05107898T ATE376559T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
AT04701585T ATE458753T1 (de) | 2003-01-14 | 2004-01-13 | Methoden der verhinderung und behandlung der alzheimer'schen krankheit |
Country Status (15)
Country | Link |
---|---|
US (2) | US7732568B2 (de) |
EP (2) | EP1679319B1 (de) |
JP (2) | JP4547373B2 (de) |
CN (2) | CN1826354B (de) |
AT (3) | AT413945B (de) |
CA (1) | CA2513218C (de) |
CY (2) | CY1107146T1 (de) |
DE (2) | DE602004009705T2 (de) |
DK (2) | DK1679319T3 (de) |
ES (2) | ES2296084T3 (de) |
HK (1) | HK1091499A1 (de) |
PL (1) | PL209989B1 (de) |
PT (2) | PT1679319E (de) |
SI (1) | SI1583774T1 (de) |
WO (1) | WO2004062556A2 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056318A2 (en) | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
EP1711208A2 (de) * | 2004-01-28 | 2006-10-18 | Curix APS | Konjugate von amyloid-proteinen als impfstoffe gegen amyloid-bedingte erkrankungen |
AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
AU2006319358B2 (en) | 2005-11-30 | 2012-01-19 | AbbVie Deutschland GmbH & Co. KG | Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
KR20140087058A (ko) | 2005-11-30 | 2014-07-08 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
SG10201404801YA (en) * | 2005-12-12 | 2014-09-26 | Ac Immune Sa | Monoclonal antibody |
EP1878747A1 (de) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Glyco-hergestellte Antikörper |
WO2008011348A2 (en) * | 2006-07-14 | 2008-01-24 | Ac Immune S.A. | Humanized antibody against amyloid beta |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
EP2124952A2 (de) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Verfahren zur behandlung von amyloidosen |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
US8048420B2 (en) * | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
KR101670088B1 (ko) * | 2007-06-12 | 2016-10-28 | 에이씨 이뮨 에스.에이. | 아밀로이드 베타에 대해 인간화된 항체 |
RU2542967C2 (ru) * | 2007-10-05 | 2015-02-27 | Дженентек, Инк. | Применение антитела против амилоида бета при глазных заболеваниях |
RU2482876C2 (ru) * | 2007-10-05 | 2013-05-27 | Дженентек, Инк. | Применение антитела против амилоида-бета при глазных заболеваниях |
RU2538709C2 (ru) * | 2007-10-05 | 2015-01-10 | Дженентек, Инк. | Гуманизированное антитело |
JP5219225B2 (ja) * | 2007-10-25 | 2013-06-26 | 国立大学法人 鹿児島大学 | アミロイドβペプチドのミミック分子を用いたペプチドワクチン |
CN104098695B (zh) * | 2007-10-29 | 2018-09-07 | 道健康生活医药株式会社 | 抗体及其应用 |
EP2278998A1 (de) | 2008-04-17 | 2011-02-02 | Declion Pharmaceuticals, Inc. | Entwurf und synthese von polymerzusammensetzungen mit gezielter sequenz und antikörper davon zur behandlung von proteinkonformationsstörungen |
AT506819B1 (de) | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
EP2310032A2 (de) * | 2008-06-12 | 2011-04-20 | Affiris AG | Verbindungen zur behandlung der symptome von parkinson-krankheit |
AT506820B1 (de) * | 2008-06-12 | 2011-07-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzine gegen alzheimer-krankheit |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
WO2012016173A2 (en) | 2010-07-30 | 2012-02-02 | Ac Immune S.A. | Safe and functional humanized antibodies |
WO2012024187A1 (en) | 2010-08-14 | 2012-02-23 | Abbott Laboratories | Amyloid-beta binding proteins |
US20120321694A1 (en) * | 2010-10-27 | 2012-12-20 | Daniel Larocque | Compositions and uses |
GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
PL2579042T3 (pl) | 2011-10-04 | 2014-12-31 | Affiris Ag | Sposób wykrywania przeciwciał swoistych wobec Aß w próbce biologicznej |
EP2787347A1 (de) | 2013-04-03 | 2014-10-08 | Affiris AG | Verfahren zur Erkennung von Aß-spezifischen Antikörpern in einer biologischen Probe |
US10381614B2 (en) * | 2013-04-17 | 2019-08-13 | Samsung Sdi Co., Ltd. | Battery module |
WO2015165961A1 (en) | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
WO2017076873A1 (en) | 2015-11-03 | 2017-05-11 | Affiris Ag | Method for vaccination against a self-antigen in a human patient |
CN105237628B (zh) * | 2015-11-17 | 2018-08-07 | 南开大学 | 一种用于治疗阿尔兹海默症的多肽 |
CN107022019B (zh) * | 2016-11-24 | 2020-10-30 | 桂林医学院 | 一种用于脑内降铁除自由基的多肽、制备方法与应用 |
WO2023161526A1 (en) | 2022-02-28 | 2023-08-31 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
GB9022190D0 (en) * | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
US5639603A (en) * | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US7964192B1 (en) * | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US6088993A (en) | 1999-02-05 | 2000-07-18 | Irace; Francisco D. | Closure system |
CA2363118A1 (en) | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
US6703491B1 (en) * | 1999-03-17 | 2004-03-09 | Exelixis, Inc. | Drosophila sequences |
IL142948A0 (en) * | 1999-09-03 | 2002-04-21 | Univ Ramot | Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
BR0108924A (pt) | 2000-03-03 | 2003-04-29 | Smithkline Beecham Biolog | Composição umonogênica adaptada para administração a um hospedeiro humano para o tratamento ou prevenção da aterosclerose, vacina, e, método de tratamento ou profilaxia da aterosclerose |
GB0024200D0 (en) * | 2000-10-03 | 2000-11-15 | Smithkline Beecham Sa | Component vaccine |
ES2276732T3 (es) | 2001-09-03 | 2007-07-01 | Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. | Mimotopos de antigenos y vacuna contra enfermedades cancerosas. |
ES2327773T3 (es) * | 2002-05-07 | 2009-11-03 | Institut Pasteur | Seleccion de peptidos que unhiben la union de pp1c a proteinas bcl-2, bcl-xl y bcl-w. |
-
2003
- 2003-09-17 AT AT0146403A patent/AT413945B/de not_active IP Right Cessation
-
2004
- 2004-01-13 WO PCT/EP2004/000162 patent/WO2004062556A2/en active Application Filing
- 2004-01-13 EP EP05107898A patent/EP1679319B1/de not_active Expired - Lifetime
- 2004-01-13 DK DK05107898T patent/DK1679319T3/da active
- 2004-01-13 EP EP04701585A patent/EP1583774B1/de not_active Expired - Lifetime
- 2004-01-13 AT AT05107898T patent/ATE376559T1/de active
- 2004-01-13 PL PL378333A patent/PL209989B1/pl unknown
- 2004-01-13 CN CN200480002213.2A patent/CN1826354B/zh not_active Expired - Fee Related
- 2004-01-13 SI SI200431399T patent/SI1583774T1/sl unknown
- 2004-01-13 CN CN2011103110387A patent/CN102526699A/zh active Pending
- 2004-01-13 ES ES05107898T patent/ES2296084T3/es not_active Expired - Lifetime
- 2004-01-13 ES ES04701585T patent/ES2339447T3/es not_active Expired - Lifetime
- 2004-01-13 US US10/540,551 patent/US7732568B2/en not_active Expired - Fee Related
- 2004-01-13 DE DE602004009705T patent/DE602004009705T2/de not_active Expired - Lifetime
- 2004-01-13 JP JP2006500553A patent/JP4547373B2/ja not_active Expired - Fee Related
- 2004-01-13 CA CA2513218A patent/CA2513218C/en not_active Expired - Fee Related
- 2004-01-13 PT PT05107898T patent/PT1679319E/pt unknown
- 2004-01-13 DK DK04701585.4T patent/DK1583774T3/da active
- 2004-01-13 PT PT04701585T patent/PT1583774E/pt unknown
- 2004-01-13 DE DE602004025668T patent/DE602004025668D1/de not_active Expired - Lifetime
- 2004-01-13 AT AT04701585T patent/ATE458753T1/de active
-
2006
- 2006-10-27 HK HK06111905.5A patent/HK1091499A1/xx not_active IP Right Cessation
-
2008
- 2008-01-17 CY CY20081100069T patent/CY1107146T1/el unknown
-
2010
- 2010-03-08 JP JP2010051012A patent/JP5282058B2/ja not_active Expired - Fee Related
- 2010-04-01 US US12/752,451 patent/US20110015131A1/en not_active Abandoned
- 2010-05-07 CY CY20101100399T patent/CY1110634T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA14642003A (de) | Impfstoff für die alzheimer-krankheit | |
TW200602071A (en) | Methods for preventing and treating alzheimer's disease (ad) | |
AT500379B1 (de) | Tau-proteine | |
ATE283289T1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
WO2001068708A3 (en) | Human and humanized fap-alpha-specific antibodies | |
BRPI0513959A (pt) | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
EP2292648A3 (de) | Kleine Streptococcus-pyogenes-Antigene und Verwendung dafür | |
NO20025064L (no) | RGO koblet til peptider | |
EP2628750A3 (de) | Gezielte Identifikation von immunogenen Peptiden | |
SE9800504D0 (sv) | Novel peptide/protein, diagnostic reagent and kit for detection of rickettsiosis | |
DE50111112D1 (de) | Hyphenspezifische faktoren aus candida albicans | |
WO2007030771A3 (en) | Targeted identification of immunogenic peptides | |
WO2004053117A3 (en) | Serine protease | |
DE60122721D1 (de) | Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers | |
WO2004011496A3 (en) | Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof | |
ATE512981T1 (de) | Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen | |
DE50210281D1 (de) | Identifizierung von ses-1 aus c. elegans sowie dessen verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EIH | Change in the person of patent owner | ||
PC | Change of the owner |
Owner name: WALTER SCHMIDT, AT Effective date: 20170329 Owner name: FRANK MATTNER, AT Effective date: 20170329 |
|
MM01 | Lapse because of not paying annual fees |
Effective date: 20191115 |